Asymptomatic  ||| S:0 E:13 ||| NNP
MS  ||| S:13 E:16 ||| NNP
Asymptomatic  ||| S:16 E:29 ||| NNP
multiple  ||| S:29 E:38 ||| JJ
sclerosis  ||| S:38 E:48 ||| NNS
( ||| S:48 E:49 ||| -LRB-
MS ||| S:49 E:51 ||| NNP
)  ||| S:51 E:53 ||| -RRB-
or  ||| S:53 E:56 ||| CC
subclinical  ||| S:56 E:68 ||| JJ
MS  ||| S:68 E:71 ||| NNP
describes  ||| S:71 E:81 ||| VBZ
a  ||| S:81 E:83 ||| DT
clinically  ||| S:83 E:94 ||| JJ
silent  ||| S:94 E:101 ||| JJ
disease  ||| S:101 E:109 ||| NN
state  ||| S:109 E:115 ||| NN
of  ||| S:115 E:118 ||| IN
MS  ||| S:118 E:121 ||| NNP
discovered  ||| S:121 E:132 ||| VBD
by  ||| S:132 E:135 ||| IN
chance  ||| S:135 E:142 ||| NN
either  ||| S:142 E:149 ||| CC
by  ||| S:149 E:152 ||| IN
imaging  ||| S:152 E:160 ||| NN
or  ||| S:160 E:163 ||| CC
at  ||| S:163 E:166 ||| IN
autopsy ||| S:166 E:173 ||| NN
,  ||| S:173 E:175 ||| ,
or  ||| S:175 E:178 ||| CC
with  ||| S:178 E:183 ||| IN
incidental  ||| S:183 E:194 ||| JJ
findings  ||| S:194 E:203 ||| NNS
shown  ||| S:203 E:209 ||| VBN
by  ||| S:209 E:212 ||| IN
other  ||| S:212 E:218 ||| JJ
diagnostic  ||| S:218 E:229 ||| JJ
tools  ||| S:229 E:235 ||| NNS
that  ||| S:235 E:240 ||| WDT
are  ||| S:240 E:244 ||| VBP
consistent  ||| S:244 E:255 ||| JJ
or  ||| S:255 E:258 ||| CC
suggestive  ||| S:258 E:269 ||| NN
of  ||| S:269 E:272 ||| IN
MS ||| S:272 E:274 ||| NNP
,  ||| S:274 E:276 ||| ,
and  ||| S:276 E:280 ||| CC
that  ||| S:280 E:285 ||| IN
cannot  ||| S:285 E:292 ||| RB
be  ||| S:292 E:295 ||| VB
explained  ||| S:295 E:305 ||| VBN
by  ||| S:305 E:308 ||| IN
any  ||| S:308 E:312 ||| DT
other  ||| S:312 E:318 ||| JJ
disease  ||| S:318 E:326 ||| NN
or  ||| S:326 E:329 ||| CC
condition ||| S:329 E:338 ||| NN
.  ||| S:338 E:340 ||| .
Since  ||| S:340 E:346 ||| IN
the  ||| S:346 E:350 ||| DT
early  ||| S:350 E:356 ||| JJ
1960s  ||| S:356 E:362 ||| NNS
there  ||| S:362 E:368 ||| EX
have  ||| S:368 E:373 ||| VBP
been  ||| S:373 E:378 ||| VBN
a  ||| S:378 E:380 ||| DT
number  ||| S:380 E:387 ||| NN
of  ||| S:387 E:390 ||| IN
autopsy  ||| S:390 E:398 ||| JJ
studies  ||| S:398 E:406 ||| NNS
reporting  ||| S:406 E:416 ||| VBG
cases ||| S:416 E:421 ||| NNS
,  ||| S:421 E:423 ||| ,
in  ||| S:423 E:426 ||| IN
which  ||| S:426 E:432 ||| WDT
histopathological  ||| S:432 E:450 ||| JJ
brain  ||| S:450 E:456 ||| NN
changes  ||| S:456 E:464 ||| NNS
consistent  ||| S:464 E:475 ||| JJ
with  ||| S:475 E:480 ||| IN
MS  ||| S:480 E:483 ||| NNP
were  ||| S:483 E:488 ||| VBD
found ||| S:488 E:493 ||| VBN
,  ||| S:493 E:495 ||| ,
despite  ||| S:495 E:503 ||| IN
that  ||| S:503 E:508 ||| DT
none  ||| S:508 E:513 ||| NN
had  ||| S:513 E:517 ||| VBD
any  ||| S:517 E:521 ||| DT
clinical  ||| S:521 E:530 ||| JJ
symptom  ||| S:530 E:538 ||| NN
or  ||| S:538 E:541 ||| CC
sign  ||| S:541 E:546 ||| NN
of  ||| S:546 E:549 ||| IN
the  ||| S:549 E:553 ||| DT
disease  ||| S:553 E:561 ||| NN
during  ||| S:561 E:568 ||| IN
their  ||| S:568 E:574 ||| PRP$
lifetime ||| S:574 E:582 ||| NN
.  ||| S:582 E:584 ||| .
Several  ||| S:584 E:592 ||| JJ
reports  ||| S:592 E:600 ||| NNS
have  ||| S:600 E:605 ||| VBP
also  ||| S:605 E:610 ||| RB
shown  ||| S:610 E:616 ||| VBN
that  ||| S:616 E:621 ||| IN
asymptomatic  ||| S:621 E:634 ||| JJ
first-degree  ||| S:634 E:647 ||| JJ
relatives  ||| S:647 E:657 ||| NNS
of  ||| S:657 E:660 ||| IN
MS  ||| S:660 E:663 ||| NNP
patients  ||| S:663 E:672 ||| NNS
may  ||| S:672 E:676 ||| MD
have  ||| S:676 E:681 ||| VB
oligoclonal  ||| S:681 E:693 ||| JJ
bands  ||| S:693 E:699 ||| NNS
in  ||| S:699 E:702 ||| IN
their  ||| S:702 E:708 ||| PRP$
cerebrospinal  ||| S:708 E:722 ||| JJ
fluids  ||| S:722 E:729 ||| NNS
or  ||| S:729 E:732 ||| CC
may  ||| S:732 E:736 ||| MD
turn  ||| S:736 E:741 ||| VB
out  ||| S:741 E:745 ||| RP
to  ||| S:745 E:748 ||| TO
have  ||| S:748 E:753 ||| VB
abnormal  ||| S:753 E:762 ||| JJ
evoked  ||| S:762 E:769 ||| JJ
potential  ||| S:769 E:779 ||| JJ
studies ||| S:779 E:786 ||| NNS
.  ||| S:786 E:788 ||| .
With  ||| S:788 E:793 ||| IN
the  ||| S:793 E:797 ||| DT
extensive  ||| S:797 E:807 ||| JJ
availability  ||| S:807 E:820 ||| NN
of  ||| S:820 E:823 ||| IN
MRI  ||| S:823 E:827 ||| NNP
lately ||| S:827 E:833 ||| RB
,  ||| S:833 E:835 ||| ,
the  ||| S:835 E:839 ||| DT
incidence  ||| S:839 E:849 ||| NN
of  ||| S:849 E:852 ||| IN
individuals  ||| S:852 E:864 ||| NNS
having  ||| S:864 E:871 ||| VBG
these  ||| S:871 E:877 ||| DT
studies  ||| S:877 E:885 ||| NNS
performed  ||| S:885 E:895 ||| VBN
for  ||| S:895 E:899 ||| IN
indications  ||| S:899 E:911 ||| NNS
other  ||| S:911 E:917 ||| JJ
than  ||| S:917 E:922 ||| IN
suspicion  ||| S:922 E:932 ||| NN
of  ||| S:932 E:935 ||| IN
inflammatory  ||| S:935 E:948 ||| JJ
demyelinating  ||| S:948 E:962 ||| JJ
disease  ||| S:962 E:970 ||| NN
of  ||| S:970 E:973 ||| IN
the  ||| S:973 E:977 ||| DT
central  ||| S:977 E:985 ||| JJ
nervous  ||| S:985 E:993 ||| JJ
system  ||| S:993 E:1000 ||| NN
( ||| S:1000 E:1001 ||| -LRB-
CNS ||| S:1001 E:1004 ||| NNP
)  ||| S:1004 E:1006 ||| -RRB-
such  ||| S:1006 E:1011 ||| JJ
as  ||| S:1011 E:1014 ||| IN
primary  ||| S:1014 E:1022 ||| JJ
headaches  ||| S:1022 E:1032 ||| NNS
or  ||| S:1032 E:1035 ||| CC
trauma ||| S:1035 E:1041 ||| NN
,  ||| S:1041 E:1043 ||| ,
revealing  ||| S:1043 E:1053 ||| VBG
unsuspected  ||| S:1053 E:1065 ||| JJ
brain  ||| S:1065 E:1071 ||| NN
and ||| S:1071 E:1074 ||| CC
/ ||| S:1074 E:1075 ||| NNP
or  ||| S:1075 E:1078 ||| CC
spinal  ||| S:1078 E:1085 ||| JJ
cord  ||| S:1085 E:1090 ||| NN
lesions  ||| S:1090 E:1098 ||| NNS
compatible  ||| S:1098 E:1109 ||| JJ
with  ||| S:1109 E:1114 ||| IN
MS  ||| S:1114 E:1117 ||| NNP
had  ||| S:1117 E:1121 ||| VBD
raised ||| S:1121 E:1127 ||| VBN
.  ||| S:1127 E:1129 ||| .
A  ||| S:1129 E:1131 ||| DT
number  ||| S:1131 E:1138 ||| NN
of  ||| S:1138 E:1141 ||| IN
such  ||| S:1141 E:1146 ||| JJ
case-series  ||| S:1146 E:1158 ||| NN
reported  ||| S:1158 E:1167 ||| VBD
recently  ||| S:1167 E:1176 ||| RB
had  ||| S:1176 E:1180 ||| VBD
resulted  ||| S:1180 E:1189 ||| VBN
in  ||| S:1189 E:1192 ||| IN
increased  ||| S:1192 E:1202 ||| JJ
awareness  ||| S:1202 E:1212 ||| NN
of  ||| S:1212 E:1215 ||| IN
this  ||| S:1215 E:1220 ||| DT
finding  ||| S:1220 E:1228 ||| NN
and  ||| S:1228 E:1232 ||| CC
to  ||| S:1232 E:1235 ||| TO
its  ||| S:1235 E:1239 ||| PRP$
relationship  ||| S:1239 E:1252 ||| NN
to  ||| S:1252 E:1255 ||| TO
clinical  ||| S:1255 E:1264 ||| JJ
multiple  ||| S:1264 E:1273 ||| JJ
sclerosis ||| S:1273 E:1282 ||| NN
.  ||| S:1282 E:1284 ||| .
This  ||| S:1284 E:1289 ||| DT
situation  ||| S:1289 E:1299 ||| NN
is  ||| S:1299 E:1302 ||| VBZ
now  ||| S:1302 E:1306 ||| RB
referred  ||| S:1306 E:1315 ||| VBN
as  ||| S:1315 E:1318 ||| IN
radiologically  ||| S:1318 E:1333 ||| JJ
isolated  ||| S:1333 E:1342 ||| JJ
syndrome  ||| S:1342 E:1351 ||| NN
( ||| S:1351 E:1352 ||| -LRB-
RIS ||| S:1352 E:1355 ||| NNP
)  ||| S:1355 E:1357 ||| -RRB-
and  ||| S:1357 E:1361 ||| CC
is  ||| S:1361 E:1364 ||| VBZ
the  ||| S:1364 E:1368 ||| DT
most  ||| S:1368 E:1373 ||| RBS
common  ||| S:1373 E:1380 ||| JJ
type  ||| S:1380 E:1385 ||| NN
of  ||| S:1385 E:1388 ||| IN
asymptomatic  ||| S:1388 E:1401 ||| JJ
MS ||| S:1401 E:1403 ||| NNP
.  ||| S:1403 E:1405 ||| .
Since  ||| S:1405 E:1411 ||| IN
it  ||| S:1411 E:1414 ||| PRP
is  ||| S:1414 E:1417 ||| VBZ
well  ||| S:1417 E:1422 ||| RB
known  ||| S:1422 E:1428 ||| VBN
that  ||| S:1428 E:1433 ||| IN
MS  ||| S:1433 E:1436 ||| NNP
has  ||| S:1436 E:1440 ||| VBZ
an  ||| S:1440 E:1443 ||| DT
asymptomatic  ||| S:1443 E:1456 ||| JJ
period  ||| S:1456 E:1463 ||| NN
of  ||| S:1463 E:1466 ||| IN
unknown  ||| S:1466 E:1474 ||| JJ
duration  ||| S:1474 E:1483 ||| NN
in  ||| S:1483 E:1486 ||| IN
many  ||| S:1486 E:1491 ||| JJ
individuals  ||| S:1491 E:1503 ||| NNS
preceding  ||| S:1503 E:1513 ||| VBG
its  ||| S:1513 E:1517 ||| PRP$
initial  ||| S:1517 E:1525 ||| JJ
presentation ||| S:1525 E:1537 ||| NN
,  ||| S:1537 E:1539 ||| ,
either  ||| S:1539 E:1546 ||| CC
as  ||| S:1546 E:1549 ||| IN
a  ||| S:1549 E:1551 ||| DT
clinically  ||| S:1551 E:1562 ||| JJ
isolated  ||| S:1562 E:1571 ||| JJ
syndrome  ||| S:1571 E:1580 ||| NN
or  ||| S:1580 E:1583 ||| CC
in  ||| S:1583 E:1586 ||| IN
rare  ||| S:1586 E:1591 ||| JJ
instances  ||| S:1591 E:1601 ||| NNS
as  ||| S:1601 E:1604 ||| IN
primary  ||| S:1604 E:1612 ||| JJ
progressive-MS ||| S:1612 E:1626 ||| NN
,  ||| S:1626 E:1628 ||| ,
it  ||| S:1628 E:1631 ||| PRP
is  ||| S:1631 E:1634 ||| VBZ
likely  ||| S:1634 E:1641 ||| RB
that  ||| S:1641 E:1646 ||| IN
a  ||| S:1646 E:1648 ||| DT
number  ||| S:1648 E:1655 ||| NN
of  ||| S:1655 E:1658 ||| IN
MS  ||| S:1658 E:1661 ||| NNP
patients  ||| S:1661 E:1670 ||| NNS
will  ||| S:1670 E:1675 ||| MD
be  ||| S:1675 E:1678 ||| VB
diagnosed  ||| S:1678 E:1688 ||| VBN
by  ||| S:1688 E:1691 ||| IN
chance  ||| S:1691 E:1698 ||| NN
as  ||| S:1698 E:1701 ||| IN
RIS  ||| S:1701 E:1705 ||| NNP
at  ||| S:1705 E:1708 ||| IN
an  ||| S:1708 E:1711 ||| DT
early  ||| S:1711 E:1717 ||| JJ
stage  ||| S:1717 E:1723 ||| NN
before  ||| S:1723 E:1730 ||| IN
converting  ||| S:1730 E:1741 ||| VBG
to  ||| S:1741 E:1744 ||| TO
clinical  ||| S:1744 E:1753 ||| JJ
disease ||| S:1753 E:1760 ||| NN
.  ||| S:1760 E:1762 ||| .
Currently  ||| S:1762 E:1772 ||| RB
this  ||| S:1772 E:1777 ||| DT
issue  ||| S:1777 E:1783 ||| NN
has  ||| S:1783 E:1787 ||| VBZ
gained  ||| S:1787 E:1794 ||| VBN
a  ||| S:1794 E:1796 ||| DT
wide  ||| S:1796 E:1801 ||| JJ
interest  ||| S:1801 E:1810 ||| NN
as  ||| S:1810 E:1813 ||| IN
there  ||| S:1813 E:1819 ||| EX
are  ||| S:1819 E:1823 ||| VBP
no  ||| S:1823 E:1826 ||| DT
established  ||| S:1826 E:1838 ||| JJ
protocols  ||| S:1838 E:1848 ||| NNS
regarding  ||| S:1848 E:1858 ||| VBG
how  ||| S:1858 E:1862 ||| WRB
to  ||| S:1862 E:1865 ||| TO
study  ||| S:1865 E:1871 ||| VB
and  ||| S:1871 E:1875 ||| CC
follow  ||| S:1875 E:1882 ||| VB
these  ||| S:1882 E:1888 ||| DT
individuals  ||| S:1888 E:1900 ||| NNS
or  ||| S:1900 E:1903 ||| CC
whether  ||| S:1903 E:1911 ||| IN
they  ||| S:1911 E:1916 ||| PRP
should  ||| S:1916 E:1923 ||| MD
be  ||| S:1923 E:1926 ||| VB
treated  ||| S:1926 E:1934 ||| VBN
or  ||| S:1934 E:1937 ||| CC
not ||| S:1937 E:1940 ||| RB
!  ||| S:1940 E:1942 ||| .
However ||| S:1942 E:1949 ||| RB
,  ||| S:1949 E:1951 ||| ,
not  ||| S:1951 E:1955 ||| RB
all  ||| S:1955 E:1959 ||| DT
patients  ||| S:1959 E:1968 ||| NNS
with  ||| S:1968 E:1973 ||| IN
RIS  ||| S:1973 E:1977 ||| NNP
are  ||| S:1977 E:1981 ||| VBP
predestined  ||| S:1981 E:1993 ||| VBN
to  ||| S:1993 E:1996 ||| TO
develop  ||| S:1996 E:2004 ||| VB
clinical  ||| S:2004 E:2013 ||| JJ
disease  ||| S:2013 E:2021 ||| NN
and  ||| S:2021 E:2025 ||| CC
it  ||| S:2025 E:2028 ||| PRP
was  ||| S:2028 E:2032 ||| VBD
recently  ||| S:2032 E:2041 ||| RB
shown  ||| S:2041 E:2047 ||| VBN
that  ||| S:2047 E:2052 ||| IN
the  ||| S:2052 E:2056 ||| DT
rate  ||| S:2056 E:2061 ||| NN
of  ||| S:2061 E:2064 ||| IN
conversion  ||| S:2064 E:2075 ||| NN
to  ||| S:2075 E:2078 ||| TO
clinical  ||| S:2078 E:2087 ||| JJ
MS  ||| S:2087 E:2090 ||| NNP
is  ||| S:2090 E:2093 ||| VBZ
about  ||| S:2093 E:2099 ||| IN
one-third  ||| S:2099 E:2109 ||| NN
of  ||| S:2109 E:2112 ||| IN
RIS  ||| S:2112 E:2116 ||| NNP
cases  ||| S:2116 E:2122 ||| NNS
at  ||| S:2122 E:2125 ||| IN
five  ||| S:2125 E:2130 ||| CD
years ||| S:2130 E:2135 ||| NNS
.  ||| S:2135 E:2137 ||| .
Although  ||| S:2137 E:2146 ||| IN
that  ||| S:2146 E:2151 ||| WDT
there  ||| S:2151 E:2157 ||| EX
may  ||| S:2157 E:2161 ||| MD
be  ||| S:2161 E:2164 ||| VB
some  ||| S:2164 E:2169 ||| DT
risk  ||| S:2169 E:2174 ||| NN
factors  ||| S:2174 E:2182 ||| NNS
suggestive  ||| S:2182 E:2193 ||| VBN
of  ||| S:2193 E:2196 ||| IN
a  ||| S:2196 E:2198 ||| DT
higher  ||| S:2198 E:2205 ||| JJR
or  ||| S:2205 E:2208 ||| CC
earlier  ||| S:2208 E:2216 ||| JJR
conversion  ||| S:2216 E:2227 ||| NN
to  ||| S:2227 E:2230 ||| TO
clinical  ||| S:2230 E:2239 ||| JJ
disease ||| S:2239 E:2246 ||| NN
,  ||| S:2246 E:2248 ||| ,
none  ||| S:2248 E:2253 ||| NN
are  ||| S:2253 E:2257 ||| VBP
definite  ||| S:2257 E:2266 ||| JJ
and  ||| S:2266 E:2270 ||| CC
the  ||| S:2270 E:2274 ||| DT
current  ||| S:2274 E:2282 ||| JJ
evidence  ||| S:2282 E:2291 ||| NN
is  ||| S:2291 E:2294 ||| VBZ
not  ||| S:2294 E:2298 ||| RB
supportive  ||| S:2298 E:2309 ||| JJ
of  ||| S:2309 E:2312 ||| IN
initiating  ||| S:2312 E:2323 ||| JJ
treatment  ||| S:2323 E:2333 ||| NN
in  ||| S:2333 E:2336 ||| IN
patients  ||| S:2336 E:2345 ||| NNS
diagnosed  ||| S:2345 E:2355 ||| VBN
as  ||| S:2355 E:2358 ||| IN
RIS ||| S:2358 E:2361 ||| NNP
.  ||| S:2361 E:2363 ||| .
